156
Participants
Start Date
July 13, 2023
Primary Completion Date
December 16, 2025
Study Completion Date
December 16, 2025
Questionnaires
"All patients in Arm 2 will be seen and treated by one of three ROs with an interest in participating in this study, who will be trained by the PI to perform these visits reproducibly and with rigor. These will all be regular ROs, who like most ROs administer a mix of curative and PRT in their clinical practice; like most cancer centers, there are no ROs who formally subspecialize in PRT at our institution. Notably, patients in Arm 1 (control arm) will always have standard-of-care RO referral available for consideration of PRT if needed for symptom relief. However, patients in Arm 1 will be seen by other ROs without any specific training for this study. Any courses of PRT administered in either arm are at the discretion of the treating RO in terms of the timing, dose, fractionation, and treatment technique."
Early Radiation Oncology Involvement Alongside Standard Oncologic Care
Early Radiation Oncology Involvement Alongside Standard Oncologic Care
RECRUITING
RWJBarnabas Health Jersey City Medical Center, Jersey City
RECRUITING
Rutgers Cancer Institute of New Jersey, New Brunswick
RECRUITING
RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RECRUITING
Malcolm David Mattes, MD, Newark
RECRUITING
RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
RECRUITING
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset
Rutgers, The State University of New Jersey
OTHER